HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Model of recurrent pulmonary aspergillosis in rats.

Abstract
Male Sprague-Dawley rats were treated with cortisone acetate and fed a low-protein diet for 3 weeks. At the end of week 2, animals were infected intratracheally with 10(5) conidia of Aspergillus fumigatus H11-20. Despite discontinuation of steroids and the low-protein diet 1 week after the infection, 94% of controls died of invasive pulmonary aspergillosis within 3 weeks postinfection. When rats were treated with a single dose of 1.6 mg of aerosolized amphotericin B per kg of body weight 48 h prior to the infection, mortality was reduced to 11% within 3 weeks postinfection. Despite apparent good health and rapid weight gain, all survivors showed multiple lesions in histopathological sections of the lungs, and 10(3) to 10(4) CFU of aspergilli was recovered from cultures of their lungs. With discontinuation of immunosuppression, the infection was slowly cleared; however, when cortisone acetate was restarted during week 5, reactivation of progressive invasive pulmonary aspergillosis was observed. On the basis of these results, we conclude that a single low dose of aerosolized amphotericin B prophylaxis is effective in preventing an exogenous aspergillus infection of the lung. Additional therapy is needed to prevent recurrent infection caused by endogenous aspergilli when immunosuppression is resumed.
AuthorsY Niki, E M Bernard, F F Edwards, H J Schmitt, B Yu, D Armstrong
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 29 Issue 7 Pg. 1317-22 (Jul 1991) ISSN: 0095-1137 [Print] United States
PMID1885728 (Publication Type: Journal Article)
Chemical References
  • Amphotericin B
Topics
  • Amphotericin B (pharmacology)
  • Animals
  • Aspergillosis (etiology, pathology, prevention & control)
  • Chronic Disease
  • Disease Models, Animal
  • Immune Tolerance
  • Lung Diseases, Fungal (etiology, pathology, prevention & control)
  • Male
  • Rats
  • Rats, Inbred Strains
  • Recurrence
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: